We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cellular Goods Plc | LSE:CBX | London | Ordinary Share | GB00BK964W87 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.375 | 0.35 | 0.40 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Catalog, Mail-order Houses | 67k | -3.31M | -0.0055 | -0.27 | 903.38k |
Date | Subject | Author | Discuss |
---|---|---|---|
07/12/2021 11:33 | The move to 10p recently looks corrective. That means we could be going sub-1p here. DYOR | david gruen | |
07/12/2021 11:30 | I can assure people that i have zero intention of trying to buy back in as they say. I am openly discussing what I see as many numerous pitfalls of investing in CBX and comparing them to a company that is using Cannabinoids but with medical licenses and potential to do so much good. If you see this as some master plan to buy CBX at a penny less then i think stock investing is the wrong game for you. Read the below: £42 BILLION market is not to be sniffed at.. And that is the market OCTP are targeting. Imperial Brands, Casa Verde as backers LONDON — Oxford Cannabinoid Technologies (OCTP), which enjoys backing from rapper Snoop Dogg and tobacco giant Imperial Brands, launched Friday on the London Stock Exchange. The British company, which specializes in pain-alleviating cannabinoid drug development, raised gross proceeds of £16.5 million ($23.4 million) in its initial public offering, with a starting market value of just over £48 million ($69.1 million). The share price hovered at around 5 pence at midday Friday, after opening near 8 pence. Snoop Dogg, real name Calvin Broadus Jr., has invested in multiple cannabis start-ups including OCT through his venture capital firm Casa Verde. His firm has also backed plant-based food companies such as Outstanding Foods and tech names like Klarna, Robinhood and Reddit. Cannabinoids are naturally occurring compound chemicals found in the cannabis sativa plant and are commonly used for medicinal purposes to treat symptoms such as chronic pain. Oxford Cannabinoid CEO: We want to get our product into the hands of physicians and patients OCTP’s strategy is to develop cannabinoid pharmaceuticals for the nonaddictive treatment of pain conditions. CEO John Lucas told CNBC on Friday the company plans to use the proceeds of its IPO to develop four new drugs. “The key here is about getting cannabinoids into the hands of patients, and the way you do that is through the drug development process,” Lucas told CNBC’s “Squawk Box Europe.” “The medical cannabis, the problem with that is that physicians cannot prescribe it, so we want a drug product that we can get into the hands of physicians, into the hands of patients.” In its listing announcement, OCTP said its “primary market focus is the total addressable pain market, which is estimated to be worth at least £42.5 billion | whites123 | |
07/12/2021 10:10 | I think CBX holders with average of 10p and lower will get an opportunity to break even, but like others before have said I dont think that will come until into 2022. The market for CBD products is flooded already. Even the new CEO came from a background where she was involved in releasing CBD products years ago. Its like trying to compete in a market for sandwiches after M&S have been doing them for 5 years already, along with every other supermarket chain. And suddenly your product is more expensive, has no history, no checkable factual evidence to show it works, but is much more expensive. I took the decision to sell at a large loss... Thankfully i did as I have saved myself from a further 30% drop in recent days and am pleased with where my investment is now heading. Oxford Cannabinoid. "OCTP" In all honesty I believe fully that in time this will surpass a 10, 20, 30 bagger with ease, but it will not be about in the form we know it today. It will be bought out by big pharma. For the past 2 years big pharma has been directing resources at Covid. Whilst they have many thousands of scientists you just need to look to Moderna to see other ground breaking work has taken a back seat. Leaving it down to the small companies like OCTP to carry on the research. What better research to be involved in that to find a pain relief that will assist those living with deadly diseases every day. They make no bones about hiding the target is the Multi Billion £ pain relief market as just one target. There are many hundreds of cannabinoids and we all know the wonderful well being properties this natural plant can provide. At 50% lower than IPO and with big backers like Imperial Brands, is it not prudent to at least buy a few of these and tuck them away? I certainly think so, so my few million shares are planted, and despite showing a profit already on them, i consider to add more to average up. :-) Not very often in my share dealing career I have been happy to average up, but then never came across a stock with so much potential as OCTP before. Its nothing like the other cannabis stocks which attract attention at present. CBX, KNB etc, these outfits are just fighting for the same consumer for CBD products along with thousands of others. No medical licenses and no medical properties, just a claim that it can make you look younger.. LOL | whites123 | |
06/12/2021 18:35 | As long as she ticks the 10 bagger box | oapknob1 | |
06/12/2021 15:23 | IDP going like a train. | gregpeck7 | |
06/12/2021 14:50 | I think that there will be another bite at the cherry from late January so will be buying back in then. This is assuming that they don't announce some large sales before then. | ashleyjv | |
06/12/2021 14:31 | I have accepted I'm never breaking even on this | bigballsbob1 | |
06/12/2021 14:13 | I announced my selling off last week of CBX despite holding at a loss for a long time. Hindsight is wonderful and I am so glad i did sell. I do of course hope you all claw your losses back. In the meantime CBX are up against essentially thousands of CBD producers who put it into any item that can. You can buy CBD oil for £30 a pop for a 25ml bottle for human consumption then buy the exact same oil in 250ml bottle from the vets for your dog. The market is IMO saturated and we all know the healing properties come from the THC content.. OCTP is my pick of the cannabis plays. Licensed and concentrating on medical issues like cancer pain. Now this is something I want to see become big... Imagine the company producing pain relief for sufferers the world over from debilitating diseases. WOW: Hence the reasons I am now all in OCTP. Oxford cannabinoid | whites123 | |
06/12/2021 11:46 | The whole sector is oversold including all the big North American cannabis stocks. | sunnysideup1 | |
06/12/2021 11:03 | Looking oversold now, expect a reversal soon , | 7rademark | |
06/12/2021 08:16 | Seems to have the track record but I dont suppose you mean that? | alloa2003 | |
06/12/2021 07:36 | I wonder how many boxes Anna Chokina ticks? | david gruen | |
06/12/2021 07:35 | Good move with the new CEO - looks like the lady is very experienced. | alloa2003 | |
03/12/2021 09:18 | Chill Brands Group (CHLL) looks the better bet, as it's already selling dozens of products in thousands of stores, and product plus store rollout is continuing. | tell sid | |
03/12/2021 07:22 | Sit back and relax | datait | |
03/12/2021 07:08 | No nasty surprises with the figures - ahead of schedule if anything. | alloa2003 | |
02/12/2021 23:12 | Sell up and jog on then. | oapknob1 | |
02/12/2021 18:10 | Your pish is criminal.The skincare and ingestible product ranges will be available to purchase from early December 2021 accompanied by a comprehensive marketing activation, building to a full omni-channel launch at the start of February 2022. The timings are in-line with industry best-practice whereby new beauty and wellness products typically go on sale early in the year to coincide with consumers' focus on self-care and forming positive habits, as well as avoiding the hyper competitive pre-Christmas rush where return on ad spend is poor for new entrants. | oapknob1 | |
02/12/2021 16:23 | CCR1958, You seem to be setting up the company for a fall. If you had read the recent announcement you would have seen that due to advertising expense and competition during the festive period, they were not going to make a big push for Xmas this year. Whether you agree or not they have been upfront about the reasons so suggesting that:- "Also if they miss Xmas which looks like they are ,it’s criminal" They have already answered your question. | alloa2003 | |
02/12/2021 16:04 | Also if they miss Xmas which looks like they are ,it’s criminal.. | ccr1958 | |
02/12/2021 12:51 | Mr down ticker, why not supply something interesting. From their RNS in October, it looks like full marketing will start from February 22. Anyway here is latest YouTube video talking about product launch https://youtu.be/Z_Z | kickingking | |
02/12/2021 12:04 | Support at 5.5p | notknowing |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions